Purpose

The Campus Bio-Medico University Hospital offers molecular tests aimed at personalizing the therapeutic path of patients with cancer, the PROSIGNA test fits into this line.

PROSIGNA is a molecular test (CE-IVD and FDA approved) useful for defining the risk of recurrence of metastatic disease ten years after surgery in women operated on for hormone-sensitive postmenopausal breast cancer. The test investigates the expression profile of a group of 50 genes known as PAM50. The pool of genes analyzed also makes it possible to classify breast cancer into the various molecular subtypes, providing more information to establish the most suitable therapeutic pathway.

when

The aim of the workshop is to illustrate the rational, scientific and clinical basis of the molecular classification of breast cancer through the use of the Prosigna Test. The preliminary results of the clinical trial "PAM50/Ki67" - Campus Bio-Medico University Hospital will be presented.

About

The course is aimed at oncologists, pathologists, surgeons, radiotherapists for a total of 70 participants.

As a

Workshop program:

  • 03:30 pm Welcome Coffee and participant registration
  • 04:00 pm Opening of works: Vittorio Altomare, Andrea Onetti Muda, Giuseppe Tonini, Lucio Trodella
  • 16:20 Therapeutic and Clinical implications of the genomic landscape of breast cancer: Aleix Prat
  • 05:00 pm Contribution of the New Generation Genomic Test in Clinical Practice: Merits of Prosigna for Early Breast Cancer Decision Making: Pascale Morel
  • 05:30 pm Preliminary results Clinical Trial "PAM 50-Ki67" (Coordinating Centre: UCBM): Giuseppe Perrone
  • 06:00 pm Discussion
  • 18: 30 Aperitif

Where

Trapeze Building - Aula Magna - Università Campus Bio-Medico di Roma: Via Álvaro del Portillo, 21 - 00128 Rome

Registration

To register you need to send an e-mail to: [email protected] no later than June 4, 2015. Registration for the Workshop is free.

Faculty
  • Vittorio Altomare - Head of UOS Senology, Associate Professor of General Surgery Università Campus Bio-Medico di Roma
  • Pascale Morel - Director of Medical Affairs EMEA, Diagnostic, Nanostring Technologies, Inc. France
  • Andrea Onetti Muda - Full Professor of Pathological Anatomy, Rector Università Campus Bio-Medico di Roma
  • Giuseppe Perrone - UOC Pathological Anatomy, Associate Professor Pathological Anatomy Università Campus Bio-Medico di Roma
  • Aleix Prat - Head Medical Oncology Department, Hospital Clínic de Barcelona, ​​Barcelona, ​​Spain Associate Professor, University of Barcelona
  • Giuseppe Tonini - Head of the Oncology Unit, Full Professor of Oncology Università Campus Bio-Medico di Roma
  • Lucio Trodella - Full Professor Radiotherapy and Radiodiagnostics, Università Campus Bio-Medico di Roma.
Final certificate

Participation in the Workshop requires the issuing of a certificate of participation by theUniversità Campus Bio-Medico di Roma.

Partners and Patronages

>> Prosigna